Stephanie Kornan
Vice President of Investor Relations, Communication and Commercial Strategy
Replay available
Innate Pharma S.A. (IPHA) Q1 2026 Earnings Call
Innate Pharma S.A. (NASDAQ: IPHA) Q1 2026 earnings conference call, held 2026-05-13. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Jonathan Dickinson
Chief Executive Officer
Sonia Quarantino
Chief Medical Officer
Yanis Morel
Chief Operating Officer
Dana Graybosh
Analyst, Learing Partners
Christopher Liu
Analyst, Lucid Capital Markets
Yigit Mukherjee
Analyst, BTIG
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Innate Pharma Sa Class A.
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.817 Ladies and gentlemen, thank you for joining us and welcome to the Nate Farmer First Quarter 00:00:04.817 -- 00:00:06.219 2026 00:00:06.219 -- 00:00:11.325 Business Update and Financial Results. After today's remarks, we will host a 00:00:11.325 -- 00:00:16.091 question and answer session. If you'd like to ask a question, please press Start 1 on 00:00:16.091 -- 00:00:20.557 your telephone keypad to raise your hand. I will now hand the conference over to Stephanie 00:00:20.557 -- 00:00:26.184 Kornan, Vice President of Investor Relations, Communication and Commercial Strategy 00:00:26.184 -- 00:00:30.026 at Nate Farmer. Please go ahead. 00:00:30.372 -- 00:00:32.635 Good morning and good afternoon, everyone. 00:00:32.635 -- 00:00:37.340 Thank you for joining us for EnateParma's Q1 2026 00:00:37.340 -- 00:00:40.904 Business Update and Financial Results Conference Call. 00:00:40.904 -- 00:00:46.110 The press release and today's presentation are both available on the IR section of 00:00:46.110 -- 00:00:47.832 our website. 00:00:47.832 -- 00:00:52.958 Before we begin, I would like to remind everyone that today's presentation includes 00:00:52.958 -- 00:00:56.622 forward-looking statements based on current expectations. 00:00:56.622 -- 00:01:01.644 These statements involve risks and uncertainties that could cause actual results 00:01:01.644 -- 00:01:04.165 to differ materially. 00:01:04.587 -- 00:01:09.713 To briefly cover today's agenda, our CEO, Jonathan Dickinson, will begin with 00:01:09.713 -- 00:01:15.139 a strategic overview and outlook. Sonia Quarantino, our chief medical officer, 00:01:15.139 -- 00:01:20.144 and Yanis Morel, our chief operating officer and I, will then provide 00:01:20.144 -- 00:01:23.588 updates on Lactamab, IPH45...